212 related articles for article (PubMed ID: 30090010)
1. Fourth-generation quinolones in the treatment of
An Y; Wang Y; Wu S; Wang YH; Qian X; Li Z; Fu YJ; Xie Y
World J Gastroenterol; 2018 Aug; 24(29):3302-3312. PubMed ID: 30090010
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori eradication with moxifloxacin-containing therapy following failed first-line therapies in South Korea.
Kang KK; Lee DH; Oh DH; Yoon H; Shin CM; Park YS; Kim N; Jung HC
World J Gastroenterol; 2014 Jun; 20(22):6932-8. PubMed ID: 24944485
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of second-line regimens for
Chang YL; Tung YC; Tu YK; Yeh HZ; Yang JC; Hsu PI; Kim SE; Wu MF; Liou WS; Shiu SI
BMJ Open Gastroenterol; 2020 Sep; 7(1):. PubMed ID: 32883715
[TBL] [Abstract][Full Text] [Related]
4. Review: A Japanese population-based meta-analysis of vonoprazan versus PPI for Helicobacter pylori eradication therapy: Is superiority an illusion?
Dong SQ; Singh TP; Wei X; Yao H; Wang HL
Helicobacter; 2017 Dec; 22(6):. PubMed ID: 28884937
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis: is combination of tetracycline and amoxicillin suitable for Helicobacter pylori infection?
Lv ZF; Wang FC; Zheng HL; Wang B; Xie Y; Zhou XJ; Lv NH
World J Gastroenterol; 2015 Feb; 21(8):2522-33. PubMed ID: 25741163
[TBL] [Abstract][Full Text] [Related]
6. Standard triple therapy for Helicobacter pylori infection in China: a meta-analysis.
Wang B; Lv ZF; Wang YH; Wang H; Liu XQ; Xie Y; Zhou XJ
World J Gastroenterol; 2014 Oct; 20(40):14973-85. PubMed ID: 25356059
[TBL] [Abstract][Full Text] [Related]
7. Optimum duration of regimens for Helicobacter pylori eradication.
Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
[TBL] [Abstract][Full Text] [Related]
8. Update on quinolone-containing rescue therapies for
Mori H; Suzuki H
World J Gastroenterol; 2020 Apr; 26(15):1733-1744. PubMed ID: 32351290
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Helicobacter pylori eradication therapies in Korea: A systematic review and network meta-analysis.
Jung YS; Park CH; Park JH; Nam E; Lee HL
Helicobacter; 2017 Aug; 22(4):. PubMed ID: 28425141
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-Analysis.
Marin AC; Nyssen OP; McNicholl AG; Gisbert JP
Drugs; 2017 May; 77(7):765-776. PubMed ID: 28361211
[TBL] [Abstract][Full Text] [Related]
11. Systematic review and network meta-analysis: Comparative effectiveness of therapies for second-line Helicobacter pylori eradication.
Yeo YH; Hsu CC; Lee CC; Ho HJ; Lin JT; Wu MS; Liou JM; Wu CY;
J Gastroenterol Hepatol; 2019 Jan; 34(1):59-67. PubMed ID: 30169908
[TBL] [Abstract][Full Text] [Related]
12. Resistance of Helicobacter pylori to quinolones and clarithromycin assessed by genetic testing in Japan.
Yamade M; Sugimoto M; Uotani T; Nishino M; Kodaira C; Furuta T
J Gastroenterol Hepatol; 2011 Sep; 26(9):1457-61. PubMed ID: 21679250
[TBL] [Abstract][Full Text] [Related]
13. Tailored Helicobacter pylori eradication based on prior intake of macrolide antibiotics allows the use of triple therapy with optimal results in an area with high clarithromycin resistance.
Valle Muñoz J; Muñoz Gómez P; Sierra Bernal C; de Andrés E; Gómez Hernando C; Gómez Rodríguez R
Rev Esp Enferm Dig; 2019 Sep; 111(9):655-661. PubMed ID: 31345044
[TBL] [Abstract][Full Text] [Related]
14. Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials.
Lin LC; Hsu TH; Huang KW; Tam KW
World J Gastroenterol; 2016 Jun; 22(23):5445-53. PubMed ID: 27340362
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of 14-d vs 7-d moxifloxacin-based triple regimens for second-line Helicobacter pylori eradication.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 May; 21(18):5568-74. PubMed ID: 25987781
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacy of culture-based tailored therapy for Helicobacter pylori eradication with that of the traditional second-line rescue therapy in Korean patients: a prospective single tertiary center study.
Kwon YH; Kim N; Lee JY; Choi YJ; Yoon K; Nam RH; Suh JH; Lee JW; Lee DH
Scand J Gastroenterol; 2016 Mar; 51(3):270-6. PubMed ID: 26452405
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori eradication with high-dose proton pump inhibitor-amoxicillin dual therapy: A systematic review and meta-analysis.
Yeh JA; Huang HK; Chou AL; Lin HJ; Feng CL; Kuo CJ; Lai CH
Int J Antimicrob Agents; 2024 Jun; 63(6):107159. PubMed ID: 38554984
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of potassium-competitive acid blockers versus proton pump inhibitors as Helicobacter pylori eradication therapy: a meta-analysis of randomized clinical trials.
Zhang M; Pang M; Zhang M
Clinics (Sao Paulo); 2022; 77():100058. PubMed ID: 35810638
[TBL] [Abstract][Full Text] [Related]
19. Minocycline in the eradication of
Zhou K; Li CL; Zhang H; Suo BJ; Zhang YX; Ren XL; Wang YX; Mi CM; Ma LL; Zhou LY; Tian XL; Song ZQ
World J Gastroenterol; 2024 May; 30(17):2354-2368. PubMed ID: 38813048
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of vonoprazan-based regimen for Helicobacter pylori eradication: A meta-analysis of randomized clinical trials.
Yang C; Li S; Huang T; Lin H; Jiang Z; He Y; Yuan J; An H
J Clin Pharm Ther; 2022 Jul; 47(7):897-904. PubMed ID: 35247003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
